Inje University Busan Paik Hospital

Busan, Busan Gwangyeogsi 47392

0 studies enrolling now · 2 studies all time

What they study most

B-cell Malignancies, Primary Biliary Cholangitis

Studies at this site

• Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies — Running, not enrolling
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed